Sibutramine in pregnancy [1]

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 122, Issue 2, 2005, Pages 243-244

  Ramzi, Finan ^a   Elias, Dahdouh ^a   Mona, Sabra ^a   Zreik, Tony G ^b  

^a SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

SIBUTRAMINE; ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE;

ADULT; ANAMNESIS; CASE REPORT; CHROMOSOME ABERRATION; CLINICAL FEATURE; DIAGNOSTIC TEST; FEMALE; HUMAN; LETTER; OBESITY; PREGNANCY; PRIORITY JOURNAL; SPONTANEOUS ABORTION; VAGINAL DELIVERY; MALE; NEWBORN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ADULT; APPETITE DEPRESSANTS; CYCLOBUTANES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 26444497492     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.02.016     Document Type: Letter

References (5)

1. W.R. Buckett, P.C. Thomas, and G.P. Luscombe The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation Prog Neuropsychopharmacol Biol Psychiatr 12 5 1988 575 584
2. N. Finer Sibutramine: its mode of action and efficacy Int J Obes Relat Metab Disord 26 4 2002 29 33
3. Physicians' Desk Reference (PDR). 58th ed. Meridia 491-6; 2004.
4. A. Einarson, L. Bonari, M. Sarkar, K. McKenna, and G. Koren Exposure to sibutramine during pregnancy: a case series Eur J Obstet Gynecol Reprod Biol 116 1 2004 112
5. M. Kadioglu, C. Ulku, and F. Yaris Sibutramine use in pregnancy: report of two cases Birth Defects Res Clin Mol Teratol 70 8 2004 545 546